Jeongyeon Hwang

A-20: COVID-19 Illness Characteristics and Cognitive Performance in Older Adults: A Pilot Analysis

Objective: COVID-19 has been associated with cognitive changes in older adults, but the illness characteristics linked to later cognitive performance remain unclear. We examined whether selected COVID-19 illness characteristics were associated with cognitive outcomes in older adults with prior COVID-19 infection. Met...

A-74: Neurocognitive and Clinical Correlates of Parkinson’s Disease and Parkinsonian Signs in a Pilot Aging Cohort

Objective: To characterize neurocognitive, sleep, lifetime activity, and exploratory diet and alcohol differences associated with Parkinson’s disease (PD) or parkinsonian signs in an aging cohort. Method/Data Selection: Participants were 105 adults 65+ who underwent dementia research evaluation at Mount Sinai and rec...

Rapid plaque clearance with anti-amyloid therapy for Alzheimer’s disease: in consideration of donanemab treatment duration from real-world cases

ABSTRACT To assess the possibility that individualized duration of donanemab treatment might enable early pausing of therapy, and to explore the possible utility of plasma P-tau217 as a biomarker for treatment response monitoring in real-time, two unrelated patients with early-stage Alzheimer’s disease were treated wit...

Potential contributors to variable penetrance of NOTCH3 p.Arg1231Cys Variant